Document is current

Any future updates will be listed below

Correction: Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials

Crossref DOI link: https://doi.org/10.1186/s12951-023-02269-4

Published Online: 2024-01-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark